KRT5 and breast cancer: Classification of primary breast cancer RNASeq data based on high/low CEBPB/REST/CTCF revealed that, KRT5, KRT14 and KRT17 mRNAs were significantly upregulated in CEBPBhigh and CTCFlow tumors (Fig 5D and 5E).